Milka Jandric https://orcid.org/0000-0003-3814-4635 Biljana Zlojutro Danica Momcicevic Sasa Dragic Sandra Topolovac Tijana Kovacevic Pedja Kovacevic

Abstract

A 38-year-old male patient was admitted to the Medical Intensive Care Unit during the second wave of the coronavirus disease (COVID-19) pandemic presenting with fever, headache, muscle pain, and cough. The low-dose chest computed tomography (CT) result was normal, but an increased serum level of procalcitonin (PCT) was detected. Due to COVID-19, pronounced symptoms, and increased inflammatory markers, empiric antibiotic therapy was started. PCT level remained elevated despite 7 days of antimicrobial treatment. Hence, the diagnostic evaluation of the patient was expanded, and we identified medullary thyroid microcarcinoma. After diagnosis, a total thyroidectomy with cervical lymph node resection was performed, and the patient was discharged with oral levothyroxine. Control measurements of serum calcitonin and 18F-fluorodihydroxyphenylalanine positron emission tomography (18F-PET/CT) showed cervical and mediastinal lymph node metastases. Beside surgical treatment, the patient was not motivated for any adjuvant therapy and no new lesions were detected on control PET/CT two years after. In conclusion, clinicians should also consider malignancies such as medullary thyroid carcinoma as a potential cause of increased PCT levels, and as a next step should measure serum calcitonin level and perform neck ultrasound.

##plugins.themes.bootstrap3.article.details##

Keywords

medullary thyroid microcarcinoma, procalcitonin, basal calcitonin, stimulated calcitonin, PET/CT

References
[1] Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993 Feb 27;341(8844):515-8. doi: 10.1016/0140-6736(93)90277-n. PMID: 8094770; PMCID: PMC7141580.
[2] Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017 Aug 3;5:51. doi: 10.1186/s40560-017-0246-8. PMID: 28794881; PMCID: PMC5543591.
[3] Durnaś B, Wątek M, Wollny T, et al. Utility of blood procalcitonin concentration in the management of cancer patients with infections. Onco Targets Ther. 2016 Jan 22;9:469-75. doi: 10.2147/OTT.S95600. PMID: 26858528; PMCID: PMC4731001.
[4] Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med. 2000 Sep;26(9):1193-200. doi: 10.1007/s001340000624. PMID: 11089742; PMCID: PMC7095266.
[5] Kim M, Kim BH. Current Guidelines for Management of Medullary Thyroid Carcinoma. Endocrinol Metab (Seoul). 2021 Jun;36(3):514-524. doi: 10.3803/EnM.2021.1082. PMID: 34154310; PMCID: PMC8258323.
[6] Bae YJ, Schaab M, Kratzsch J. Calcitonin as Biomarker for the Medullary Thyroid Carcinoma. Recent Results Cancer Res. 2015;204:117-37. doi: 10.1007/978-3-319-22542-5_5. PMID: 26494386.
[7] Kushchayev SV, Kushchayeva YS, Tella SH, Glushko T, Pacak K, Teytelboym OM. Medullary Thyroid Carcinoma: An Update on Imaging. J Thyroid Res. 2019 Jul 7;2019:1893047. doi: 10.1155/2019/1893047. PMID: 31360432; PMCID: PMC6642782.
[8] Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Curr Oncol. 2019 Oct;26(5):338-344. doi: 10.3747/co.26.5539. PMID: 31708652; PMCID: PMC6821118.
[9] Jayasinghe R, Basnayake O, Jayarajah U, Seneviratne S. Management of medullary carcinoma of the thyroid: a review. J Int Med Res. 2022 Jul;50(7):3000605221110698. doi: 10.1177/03000605221110698. PMID: 35822284; PMCID: PMC9284230.
How to Cite
Jandric, M., Zlojutro, B., Momcicevic, D., Dragic, S., Topolovac, S., Kovacevic, T., & Kovacevic, P. (2024). Incidental diagnosis of medullary thyroid microcarcinoma in COVID-19 patient with elevated procalcitonin levels. Archive of Clinical Cases, 11(4), 98-101. https://doi.org/10.22551/2024.45.1104.10297
Section
Case Reports

How to Cite

Jandric, M., Zlojutro, B., Momcicevic, D., Dragic, S., Topolovac, S., Kovacevic, T., & Kovacevic, P. (2024). Incidental diagnosis of medullary thyroid microcarcinoma in COVID-19 patient with elevated procalcitonin levels. Archive of Clinical Cases, 11(4), 98-101. https://doi.org/10.22551/2024.45.1104.10297